Aldeyra Therapeutics, Inc.

ALDXNASDAQHealthcare● Active

$1.74

+$0.11(+6.75%)

Market Cap$104958658

P/E Ratio—

52W High$6.175

52W Low$1.07

Avg Volume3.1M

Open$1.90

Beta1.19

Net Income Financials Revenue

Aldeyra Therapeutics, Inc. (ALDX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ALDX · net income · updated Jun 8, 2026

Core profitability metrics

ALDX · net income · margin · TTM · CAGR

Net income was −$33.8M for FY2025 (fiscal year ending 2025-12-31), up 39.4% year-over-year. Net profit margin was —. Based on available data, Aldeyra Therapeutics, Inc. has been profitable since at least 2013.

FY2025 Net Income−$33.8M▲ +39.4% YoY

Trailing 12M (TTM)−$27.4Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+39.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2013

▸ FMP /income-statement · Annual · ALDX net income history · ALDX profit margin

Annual net income data

ALDX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$33.8M▲ +39.4%—$0

FY2024Loss−$55.9M▼ 48.8%—$0

FY2023Loss−$37.5M▲ +39.5%—$0

FY2022Loss−$62.0M▼ 7.4%—$0

FY2021Loss−$57.8M▼ 53.8%—$0

Net income vs peers (Healthcare)

ALDX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Aldeyra Therapeutics, Inc.YOU

ALDX

−$33.8M+39.4%—

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Aldeyra Therapeutics, Inc. (ALDX) reported net income of −$33.8M for FY2025 (fiscal year ending 2025-12-31), up 39.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Based on available data, Aldeyra Therapeutics, Inc. has been profitable since at least 2013. Net income reached a peak of $13.1M in FY2013. Data available for 15 fiscal years.

Aldeyra Therapeutics, Inc.'s net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Aldeyra Therapeutics, Inc. net worth" — the company's market capitalization is a separate figure from ALDX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ALDX net income · 4 questions

Aldeyra Therapeutics, Inc. is not currently profitable on an annual basis. The company reported a net loss of $33.8M for FY2025.

is ALDX profitabledoes ALDX make a profitALDX profitabilityALDX profitable company

▸ Source: FMP /income-statement · GAAP · Aldeyra Therapeutics, Inc. · Aldeyra Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026